OBM Transplantation (ISSN 2577-5820) is an international peer-reviewed Open Access journal published quarterly online by LIDSEN Publishing Inc., which covers all evidence-based scientific studies related to transplantation, including: transplantation procedures and the maintenance of transplanted tissues or organs; assimilation of grafted tissue and the reconstitution of removed organs or parts of organs; transplantation of heart, lung, kidney, liver, pancreatic islets and bone marrow, etc. Areas related to clinical and experimental transplantation are also of interest.

OBM Transplantation is committed to rapid review and publication, and we aim at serving the international transplant community with high accessibility as well as relevant and high quality content.

We welcome original clinical studies as well as basic science, reviews, short reports/rapid communications, case reports, opinions, technical notes, book reviews as well as letters to the editor. 


Publication Speed (median values for papers published in 2023): Submission to First Decision: 6.7 weeks; Submission to Acceptance: 14.4 weeks; Acceptance to Publication: 6 days (1-2 days of FREE language polishing included)

Current Issue: 2024  Archive: 2023 2022 2021 2020 2019 2018 2017

Special Issue

Diagnostic Requirements Including Algorithms and Biomarkers in Liver Transplantation

Submission Deadline: January 31, 2025 (Open) Submit Now

Guest Editor

Rolf Teschke, MD, Professor (Biography)

1. Department of Internal Medicine II, Division of Gastroenterology and Hepatology, Klinikum Hanau, Hanau, Germany
2. Academic Teaching Hospital of the Medical Faculty, Goethe University Frankfurt/Main, Frankfurt/Main, Germany


Research Interests: Hepatology; herbal hepatotoxicity; gastroenterology; alcoholic liver disease

About This Topic

Liver transplantation (LT) is an important life-saving option for patients with acute liver failure, complications of end-stage liver diseases like cirrhosis, and stage T2 hepatocellular carcinoma. Currently, the survival rates are 90% after 1 year and 70% after 5 years. Of importance are careful evaluation of candidates regarding indications and contraindications. Despite major diagnostic efforts, the causes of the liver diseases of published reports on LTs often remain unclear. To overcome these issues, it is mandatory to improve the diagnostic approaches to liver diseases. This is best done by using validated diagnostic causality algorithms combined with validated diagnostic biomarkers.


Liver transplantation; end-stage liver diseases; cirrhosis; hepatocellular carcinoma; diagnostic causality algorithms; diagnostic biomarkers

Manuscript Submission Information

Manuscripts should be submitted through the LIDSEN Submission System. Detailed information on manuscript preparation and submission is available in the Instructions for Authors. All submitted articles will be thoroughly refereed through a single-blind peer-review process and will be processed following the Editorial Process and Quality Control policy. Upon acceptance, the article will be immediately published in a regular issue of the journal and will be listed together on the special issue website, with a label that the article belongs to the Special Issue. LIDSEN distributes articles under the Creative Commons Attribution (CC BY 4.0) License in an open-access model. The authors own the copyright to the article, and the article can be free to access, distribute, and reuse provided that the original work is correctly cited.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). Research articles and review articles are highly invited. Authors are encouraged to send the tentative title and abstract of the planned paper to the Editorial Office (transplantation@lidsen.com) for record. If you have any questions, please do not hesitate to contact the Editorial Office.

Welcome your submission!